Combined liver transplantation and sleeve gastrectomy: report of a brief-interval staged approach
Abstract
ABSTRACT: Pretransplantation bariatric surgery in patients with high Model for End-Stage Liver Disease (MELD) score is fraught with risks. Bariatric surgery after liver transplantation (LT) may be complicated by surgical adhesions but could have advantages if performed at the time of transplantation. We investigated a method of brief-interval staging combining LT and sleeve gastrectomy (SG). LT recipients with a body mass index (BMI) > 40 kg/m 2 received an SG during the same hospitalization as the LT (LT/SG), at the same time as a planned brief-interval return to the operating room for biliary anastomosis. Differences in intraoperative attributes of the LT (Stage 1) versus SG (Stage 2) procedures were analyzed using Wilcoxon signed-rank test with significance p < 0.05 and compared with patients with obesity having a two-stage LT without SG. A total of 14 cases {median MELD score 33 (interquartile range [IQR], 18-40)} were compared with 28 controls; 60% were critically ill prior to surgery with mechanical ventilation, vasopressors, or continuous renal replacement therapy. Median interval between procedures was 16.1 (IQR, 12.5-22.7) hours for cases and 12.2 (IQR, 11.1-16.6) hours for controls, p = 0.27. Median BMI at LT/SG was 47.0 (IQR, 41.7-51.3) kg/m 2 versus 38.1 (IQR, 35.7-39.8) kg/m 2 for controls, p < 0.001. At 1 year, median excess body weight loss was 74.0% (IQR, 46.2%-78.7%) in cases and 15.8% (IQR, -5.4% to 62.6%) in controls, p = 0.13; total weight loss was 38.1% (IQR, 23.9-42.9) in cases versus 7.7% (IQR, -2.4% to 27.6%) for controls, p = 0.03. Graft survival at 1 year was 92.9% for cases and 89.3% for controls with similar early postoperative outcomes. This proof-of-concept study revealed that a brief-interval SG during LT is feasible in patients with high MELD and resulted in sustained weight loss at 1 year with similar graft survival. Further studies are needed to determine an optimal strategy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Complications specifically related to laparoscopic sleeve gastrectomy are very rare.
“Complications speci fi cally related to laparoscopic sleeve gastrectomy are very rare and long-term bene fi ts have been reported with durable weight loss (35-38%) 505,506,508 and fewer metabolic complications (IR, hypertension, T2D and metabolic syndrome and less antihypertensive and lipid-lowering medication). 505,506”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [508]
Long-term benefits of laparoscopic sleeve gastrectomy have been reported with durable weight loss (35-38%) and fewer metabolic complications.
“Complications speci fi cally related to laparoscopic sleeve gastrectomy are very rare and long-term bene fi ts have been reported with durable weight loss (35-38%) 505,506,508 and fewer metabolic complications (IR, hypertension, T2D and metabolic syndrome and less antihypertensive and lipid-lowering medication). 505,506”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [508]
The citation lists haven’t been fetched yet
References 27 · Cited by 21
- Authors
- Tariq, N., Saharia, A., Nwokedi, U., Hobeika, M. J., Mobley, C. M., Hsu, D., Potter, L. M., Moore, L. W., Elaileh, A., Sherman, V., & Ghobrial, R. M.
- Affiliations
- Houston Methodist (US)
- Corresponding author
- Tariq, Nabil
- ORCID
- Venue
- Liver Transplantation
- Published
- 2022-09-09
- Volume
- 29
- Issue
- 4
- Pages
- 422-430
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W4292089388
- Cited by
- 21
- References
- 27
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 9 · 2023: 3
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Liver Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- sleeve gastrectomy, staged surgery, obesity, MELD score, weight loss, graft survival, biliary anastomosis, surgical adhesions, critically ill patients, postoperative complications, liver cirrhosis
- MeSH terms
- Gastrectomy, Humans, Obesity, Morbid, Retrospective Studies, Severity of Illness Index, Gastric Bypass, Weight Loss, Liver Transplantation, Treatment Outcome, End Stage Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review